Skip to main content Accessibility help

Practices and outcomes of self-treatment with helminths based on physicians' observations

  • J. Liu (a1), R.A. Morey (a2), J.K. Wilson (a3) and W. Parker (a1)


The successful use of helminths as therapeutic agents to resolve inflammatory disease was first recorded 40 years ago. Subsequent work in animal models and in humans has demonstrated that the organisms might effectively treat a wide range of inflammatory diseases, including allergies, autoimmune disorders and inflammation-associated neuropsychiatric disorders. However, available information regarding the therapeutic uses and effects of helminths in humans is limited. This study probes the practices and experiences of individuals ‘self-treating’ with helminths through the eyes of their physicians. Five physicians monitoring more than 700 self-treating patients were interviewed. The results strongly support previous indications that helminth therapy can effectively treat a wide range of allergies, autoimmune conditions and neuropsychiatric disorders, such as major depression and anxiety disorders. Approximately 57% of the self-treating patients observed by physicians in the study had autism. Physicians reported that the majority of patients with autism and inflammation-associated co-morbidities responded favourably to therapy with either of the two most popular organisms currently used by self-treaters, Hymenolepis diminuta and Trichuris suis. However, approximately 1% of paediatric patients experienced severe gastrointestinal pains with the use of H. diminuta, although the symptoms were resolved with an anti-helminthic drug. Further, exposure to helminths apparently did not affect the impaired comprehension of social situations that is the hallmark of autism. These observations point toward potential starting points for clinical trials, and provide further support for the importance of such trials and for concerted efforts aimed at probing the potential of helminths, and perhaps other biologicals, for therapeutic use.


Corresponding author

*Fax: 919-684-7263 E-mail:


Hide All
Akins, R.S., Krakowiak, P., Angkustsiri, K., Hertz-Picciotto, I. & Hansen, R.L. (2014) Utilization patterns of conventional and complementary/alternative treatments in children with autism spectrum disorders and developmental disabilities in a population-based study. Journal of Developmental & Behavioral Pediatrics 35, 110.
Awasthi, S., Peto, R., Read, S., Richards, S.M., Pande, V. & Bundy, D. (2013) Population deworming every 6 months with albendazole in 1 million pre-school children in North India: DEVTA, a cluster-randomised trial. Lancet 381, 14781486.
Ball, P.A. & Bartlett, A. (1969) Serological reactions to infection with Necator americanus . Transactions of the Royal Society of Tropical Medicine and Hygiene 63, 362369.
Broadhurst, M.J., Leung, J.M., Kashyap, V., McCune, J.M., Mahadevan, U., McKerrow, J.H. & Loke, P. (2010) IL-22+ CD4+ T cells are associated with therapeutic Trichuris trichiura infection in an ulcerative colitis patient. Science Translational Medicine 2, 60ra88. doi: 10.1126/scitranslmed.3001500.
Cheng, A.M., Jaint, D., Thomas, S., Wilson, J. & Parker, W. (2015) Overcoming evolutionary mismatch by self-treatment with helminths: current practices and experience. Journal of Evolutionary Medicine 3, article ID 235910.
Correale, J. & Farez, M. (2007) Association between parasite infection and immune responses in multiple sclerosis. Annals of Neurology 61, 97108.
Elliott, D.E., Setiawan, T., Metwali, A., Blum, A., Urban, J.F. Jr & Weinstock, J.V. (2004) Heligmosomoides polygyrus inhibits established colitis in IL-10-deficient mice. European Journal of Immunology 34, 26902698.
Falcone, F.H. & Pritchard, D.I. (2005) Parasite role reversal: worms on trial. Trends in Parasitology 21, 157160.
Flowers, S. & Hopkins, M. (2013) Autoimmune disease: patients self-treat with parasitic worms. Nature 493, 163.
Hanson, E., Kalish, L.A., Bunce, E., Curtis, C., McDaniel, S., Ware, J. & Petry, J. (2007) Use of complementary and alternative medicine among children diagnosed with autism spectrum disorder. Journal of Autism and Developmental Disorders 37, 628636.
Harrington, J.W., Patrick, P.A., Edwards, K.S. & Brand, D.A. (2006) Parental beliefs about autism: implications for the treating physician. Autism 10, 452462.
Imai, S. & Fujita, K. (2004) Molecules of parasites as immunomodulatory drugs. Current Topics in Medicinal Chemistry 4, 539552.
Levy, S.E. & Hyman, S.L. (2003) Use of complementary and alternative treatments for children with autistic spectrum disorders is increasing. Pediatric Annals 32, 685691.
Levy, S.E., Mandell, D.S., Merhar, S., Ittenbach, R.F. & Pinto-Martin, J.A. (2003) Use of complementary and alternative medicine among children recently diagnosed with autistic spectrum disorder. Journal of Developmental & Behavioral Pediatrics 24, 418423.
Lukes, J., Kuchta, R., Scholz, T. & Pomajbikova, K. (2014) (Self-)infections with parasites: re-interpretations for the present. Trends in Parasitology 30, 377385.
Ogilvie, B.M., Bartlett, A., Godfrey, R.C., Turton, J.A., Worms, M.J. & Yeates, R.A. (1978) Antibody responses in self-infections with Necator americanus . Transactions of the Royal Society of Tropical Medicine and Hygiene 72, 6671.
Parker, W. & Ollerton, J. (2013) Evolutionary biology and anthropology suggest biome reconstitution as a necessary approach toward dealing with immune disorders. Evolution, Medicine, and Public Health 2013, 89103. doi: 10.1093/emph/eot008.
Parker, W., Perkins, S.E., Harker, M. & Muehlenbein, M.P. (2012) A prescription for clinical immunology: the pills are available and ready for testing. Current Medical Research and Opinion 28, 11931202. doi: 10.1185/03007995.2012.695731.
Perrin, J.M., Coury, D.L., Hyman, S.L., Cole, L., Reynolds, A.M. & Clemons, T. (2012) Complementary and alternative medicine use in a large pediatric autism sample. Pediatrics 130(Suppl. 2), S77–82.
Rook, G.A.W. (2009) Review series on helminths, immune modulation and the hygiene hypothesis: the broader implications of the hygiene hypothesis. Immunology 126, 311.
Siniscalco, D. & Antonucci, N. (2013) Possible use of Trichuris suis ova in autism spectrum disorders therapy. Medical Hypotheses 81, 14. doi: 10.1016/j.mehy.2013.03.024.
Summers, R.W., Elliott, D.E., Urban, J.F. Jr, Thompson, R. & Weinstock, J.V. (2005a) Trichuris suis therapy in Crohn's disease. Gut 54, 8790. doi: 10.1136/gut.2004.041749.
Summers, R.W., Elliott, D.E., Urban, J.F. Jr, Thompson, R.A. & Weinstock, J.V. (2005b) Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology 128, 825832.
Tilp, C., Kapur, V., Loging, W. & Erb, K.J. (2013) Prerequisites for the pharmaceutical industry to develop and commercialise helminths and helminth-derived product therapy. International Journal of Parasitology 43, 319325.
Turton, J.A. (1976) IgE, parasites, and allergy. Lancet 2, 686.
Williamson, L.L., McKenney, E.A., Holzknecht, Z.E., Belliveau, C., Rawls, J.F., Poulton, S., Parker, W. & Bilbo, S.D. (2016) Got worms? Perinatal exposure to helminths prevents persistent immune sensitization and cognitive dysfunction induced by early-life infection. Brain, Behavior, and Immunity 51, 1428. doi: 10.1016/j.bbi.2015.07.006.
Wohlleben, G., Trujillo, C., Müller, J., Ritze, Y., Grunewald, S., Tatsch, U. & Erb, K.J. (2004) Helminth infection modulates the development of allergen-induced airway inflammation. International Immunology 16, 585596.

Practices and outcomes of self-treatment with helminths based on physicians' observations

  • J. Liu (a1), R.A. Morey (a2), J.K. Wilson (a3) and W. Parker (a1)


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed